BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 27734165)

  • 1. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
    Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
    J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).
    Hilbert JE; Kissel JT; Luebbe EA; Martens WB; McDermott MP; Sanders DB; Tawil R; Thornton CA; Moxley RT;
    Contemp Clin Trials; 2012 Mar; 33(2):302-11. PubMed ID: 22155025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and correlates of apathy in myotonic dystrophy type 1.
    Gallais B; Montreuil M; Gargiulo M; Eymard B; Gagnon C; Laberge L
    BMC Neurol; 2015 Aug; 15():148. PubMed ID: 26296336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and type of cancers in myotonic dystrophy: A retrospective cross-sectional study.
    D'Ambrosio ES; Chuang K; David WS; Amato AA; Gonzalez-Perez P
    Muscle Nerve; 2023 Aug; 68(2):142-148. PubMed ID: 36790141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2.
    Hilbert JE; Barohn RJ; Clemens PR; Luebbe EA; Martens WB; McDermott MP; Parkhill AL; Tawil R; Thornton CA; Moxley RT;
    Neurology; 2017 Sep; 89(13):1348-1354. PubMed ID: 28855409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I.
    Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
    Acta Neurol Scand; 2007 Apr; 115(4):265-70. PubMed ID: 17376125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain location and intensity impacts function in persons with myotonic dystrophy type 1 and facioscapulohumeral dystrophy with chronic pain.
    Miró J; Gertz KJ; Carter GT; Jensen MP
    Muscle Nerve; 2014 Jun; 49(6):900-5. PubMed ID: 24415580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations.
    Voermans NC; van der Bilt RC; IJspeert J; Hogrel JY; Jeanpierre M; Behin A; Laforet P; Stojkovic T; van Engelen BG; Padberg GW; Sacconi S; Lemmers RJLF; van der Maarel SM; Eymard B; Bassez G
    J Neurol; 2019 Dec; 266(12):2987-2996. PubMed ID: 31471688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy.
    Jensen MP; Hoffman AJ; Stoelb BL; Abresch RT; Carter GT; McDonald CM
    Arch Phys Med Rehabil; 2008 Feb; 89(2):320-8. PubMed ID: 18226657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
    Bienias P; Łusakowska A; Ciurzyński M; Rymarczyk Z; Irzyk K; Kurnicka K; Kamińska A; Pruszczyk P
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):959-68. PubMed ID: 27444982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity.
    Banerji CRS; Henderson D; Tawil RN; Zammit PS
    Hum Mol Genet; 2020 Sep; 29(16):2746-2760. PubMed ID: 32744322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-verbal communication in patients with DM1 and FSHD].
    Michon CC; Miljkovitch R; Cyrulnik B
    Med Sci (Paris); 2018 Nov; 34 Hors série n°2():9-12. PubMed ID: 30418137
    [No Abstract]   [Full Text] [Related]  

  • 13. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
    Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
    Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of relatives on fatigue experienced by patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I.
    Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
    Eur Neurol; 2006; 56(1):24-30. PubMed ID: 16914927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of functional outcomes in patients with facioscapulohumeral muscular dystrophy.
    Katz NK; Hogan J; Delbango R; Cernik C; Tawil R; Statland JM
    Brain; 2021 Dec; 144(11):3451-3460. PubMed ID: 34542603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences with bariatric surgery in patients with facioscapulohumeral dystrophy and myotonic dystrophy type 1: A qualitative study.
    Abel EEDH; Cup EHC; Lanser A; Leclercq WKG; Raaphorst J; Padberg GW; Satink T; Voermans NC
    Neuromuscul Disord; 2018 Nov; 28(11):938-946. PubMed ID: 30342904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries.
    Higgs C; Hilbert JE; Wood L; Martens WB; Marini-Bettolo C; Nikolenko N; Alsaggaf R; Lochmüller H; Moxley RT; Greene MH; Wang Y; Gadalla SM
    Front Neurol; 2019; 10():1071. PubMed ID: 31681146
    [No Abstract]   [Full Text] [Related]  

  • 19. [Educational and Professional Qualifications of Adults With Myotonic Dystrophies - A Misleading Perception by the Myopathic Face?].
    Stahl K; Wenninger S; Schüller A; Montagnese F; Schoser B
    Fortschr Neurol Psychiatr; 2016 Apr; 84(4):211-6. PubMed ID: 27100845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.
    Suominen T; Bachinski LL; Auvinen S; Hackman P; Baggerly KA; Angelini C; Peltonen L; Krahe R; Udd B
    Eur J Hum Genet; 2011 Jul; 19(7):776-82. PubMed ID: 21364698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.